首页> 美国卫生研究院文献>Implementation Science : IS >Reconsidering low-dose aspirin therapy for cardiovascular disease: a study protocol for physician and patient behavioral change
【2h】

Reconsidering low-dose aspirin therapy for cardiovascular disease: a study protocol for physician and patient behavioral change

机译:重新考虑小剂量阿司匹林治疗心血管疾病:医师和患者行为改变的研究方案

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundThere are often disparities between current evidence and current practice. Decreasing the gap between desired practice outcomes and observed practice outcomes in the healthcare system is not always easy. Stopping previously recommended or variably recommended interventions may be even harder to achieve than increasing the use of a desired but under-performed activity. For over a decade, aspirin has been prescribed for primary prevention of cardiovascular disease and for patients with the coronary artery disease risk equivalents; yet, there is no substantial evidence of an appropriate risk-benefit ratio to support this practice. This paper describes the protocol of a randomized trial being conducted in six primary care practices in the Denver metropolitan area to examine the effectiveness of three interventional strategies to change physician behavior regarding prescription of low-dose aspirin.
机译:背景技术当前的证据与当前的实践之间经常存在差异。缩小医疗体系中期望的实践结果与观察到的实践结果之间的差距并不总是那么容易。与增加对期望的但表现不佳的活动的使用相比,停止先前推荐或不同推荐的干预措施可能更难实现。十多年来,阿司匹林已被处方用于心血管疾病的一级预防,以及具有冠心病风险的患者。但是,没有足够的证据证明适当的风险收益率可以支持这种做法。本文介绍了在丹佛大都会地区的六种初级保健实践中进行的一项随机试验的规程,以检查三种干预策略改变低剂量阿司匹林处方对医生行为的有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号